ArticleCureus2025
Stress Cardiomyopathy Following Multivisceral Transplantation: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multivisceral transplantation (MVT) is an extraordinarily complex surgical procedure that imposes significant physiological stress driven by hemodynamic instability, fluid shifts, and severe bleeding. These factors can profoundly affect cardiovascular function and increase the risk of complications. Stress cardiomyopathy (Takotsubo syndrome), a transient non-ischemic heart failure characterized by acute left ventricular dysfunction, is a recognized complication of major surgeries but has not previously been reported in the context of MVT. This case report describes the occurrence, diagnosis, perioperative management, and favorable outcome of stress cardiomyopathy in a patient undergoing MVT with intraoperative venovenous extracorporeal membrane oxygenation support. It highlights the diagnostic criteria for stress cardiomyopathy, including echocardiographic findings and the application of the InterTAK score. It emphasizes the critical importance of heightened awareness, vigilance, and timely intervention to achieve a favorable clinical outcome.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.